BMK-Y101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBMK-Y101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7Cyclin-dependent kinase 9
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSeoul National University Alumni Association In The U.S.A. Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeoul National University Alumni Association In The U.S.A. Inc
Active IndicationsN/A
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A